The Center for Genetic Engineering and Biotechnology (CIGB) in Camagüey takes advantage of the potential offered by molecular biology and genetic engineering for the production of unique drugs of its kind in the world.
In response to the current needs in the agricultural sector, affected by the intensification of the blockade imposed by the United States, the GAVAC vaccine, immunogenic against bovine cattle tick has been marketed in countries such as Venezuela, Brazil, Colombia, Nicaragua and Mexico stands out.
There is also the HeberNem, intended for the control of nematodes in plants, with significant results in the reduction of phytoparasite populations that affect open-field crops, it also constitutes a biofertilizer.
Therefore, the CIGB of Camagüey contributes to the replacement of imported vaccines that are sold at high prices in the international market. An example is the Porvac, used in the program for control and eradication of classical swine fever with great positive impact on genetic and multiplier companies.
With encouraging results in the biomedical field, this center stands out for the development of the Heberprovac vaccine, the only biotechnological product developed in Cuba against advanced prostate cancer in phases I and II, aimed at human health.
Inaugurated by Commander in Chief Fidel Castro Ruz, on July 25, 1989, the Center for Genetic Engineering and Biotechnology of Camagüey prides Cuban science. (Maykel Torres la Rosa / Radio Cadena Agramonte) (Photos: Humberto Cid González)